À propos
Partner and Patent Attorney in Mewburn Ellis LLP's Life Sciences department, Sean Constable focuses on life sciences patent work including gene editing and antibody therapeutics and represents clients in multi-party opposition proceedings before the European Patent Office. He has in‑house experience at a clinical-stage UK biopharmaceutical company and qualified as a Chartered Patent Attorney and a European Patent Attorney in 2018.
Domaines d’expertise
Intellectual PropertyLife Sciences
Bureau
Expertise
Gene editing (zinc finger nucleases, CRISPR/Cas)Antibody therapeutics (oncology and immuno-oncology)Antibody production and purification technologiesProtein engineering (enzymes for industrial fermentation)European Patent Office oppositions (multi-party)In-house experience at a clinical-stage biopharmaceutical companyWorking with UK and US biopharmaceutical companiesAdvising universities and technology transfer organisations
Formation
- BSc Biochemistry with a Year in Industry, Imperial College London
- PhD in Developmental Neurobiology, University College London (doctoral research involving gene editing technologies including CRISPR/Cas)
Inscriptions au barreau
- Chartered Patent Attorney (qualified 2018)
- European Patent Attorney (qualified 2018)